Which has grown faster, CAMP or QTTB?

Over the past five years, QTTB grew revenue faster — CAMP at a -57.68% CAGR versus QTTB at 10.22%.

Is CAMP or QTTB more profitable?

QTTB runs the higher net margin — CAMP at -2543.74% versus QTTB at 62.87%.

CAMP4 Therapeutics Corporation (CAMP) vs Q32 Bio Inc. (QTTB)

A side-by-side comparison of CAMP4 Therapeutics Corporation and Q32 Bio Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CAMP

CAMP4 Therapeutics Corporation

$243M

$3.88HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT

QTTB

Q32 Bio Inc.

$242M

$8.14HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — CAMP vs QTTB

growth of $100 · dividends reinvested · last 2y

CAMP -62.6% (-38.8%/yr)QTTB -82.3% (-58.0%/yr)CAMP compounded faster over this window

CAMP QTTB

CAMP vs QTTB: by the numbers

•CAMP is the larger company ($243M vs $242M market cap).
•QTTB is profitable (62.87% net margin) while CAMP runs a net loss (-2543.74%).
•QTTB grew revenue faster over the past five years (10.22% vs -57.68% CAGR).

Metrics side by side

Valuation

Metric	CAMP	QTTB
P/E ratio	N/A	2.92
P/S ratio	57.75	4.51
P/B ratio	N/A	2.29
EV / EBITDA	N/A	6.45

Profitability

Metric	CAMP	QTTB
Gross margin	53.14%	99.84%
Operating margin	-1488.31%	31.45%
Net margin	-2543.74%	62.87%
ROE	N/A	31.90%
ROIC	-69.76%	19.43%

Growth (annualized)

Metric	CAMP	QTTB
Revenue CAGR (5Y)	-57.68%	10.22%
Total return CAGR (5Y)	N/A	-41.51%

Frequently asked

Which has grown faster, CAMP or QTTB?: Over the past five years, QTTB grew revenue faster — CAMP at a -57.68% CAGR versus QTTB at 10.22%.
Is CAMP or QTTB more profitable?: QTTB runs the higher net margin — CAMP at -2543.74% versus QTTB at 62.87%.

Go deeper

Full CAMP analysis Full QTTB analysis Interactive comparison tool

Dig into the metrics

Q32 Bio P/E ratio CAMP4 Therapeutics ROE Q32 Bio ROE CAMP4 Therapeutics operating margin Q32 Bio operating margin CAMP4 Therapeutics revenue growth Q32 Bio revenue growth CAMP4 Therapeutics free cash flow Q32 Bio free cash flow

CAMP4 Therapeutics & Q32 Bio appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.